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Cancer is the term for diseases in which a group of previously normal cells have gone 
through a serial genetic alteration in their DNAs and eventually appear uncontrolled self 
growing, infectiveness to surrounding tissues and capability of spreading to other places of 
the body. 
 
Radiation therapy as a cancer treatment method is considered as a great revolution in the 
history of medicine. It uses high-energy ionizing radiation to disrupt the cellular dividing, 
which will ultimately cause the death of the cancer cells. In Radiation therapy, treatment 
planning system software is often used in treatment planning phase. Its main usage is to 
generate the virtualized beam shapes and dose distributions with the intention to help 
clinicians to maximize the tumor control and minimize the normal tissue complications for 
the cancer patient.   
 
In this work, automated tests are developed for verifying a large set of checking functions 
executed in a treatment planning system software. The objective of implementing these 
automated tests is to intentionally violate the rules in order to check whether the expected 
error or warning message are thrown by the checking functions and are correctly shown to the 
user. 
Keywords: Automated Test, Cancer, Radiation Therapy, Treatment Planning System, Risk 
Management in Radiation Therapy, Software Testing 
AALTO UNIVERSITY 
SCHOOL OF ELECTRICAL ENGINEERING 
ABSTRACT OF THE  
MASTER’S THESIS 
   
Preface	  
This Master’s Thesis was done in a company that develops software for radiation 
therapy devices. In order to protect the company’s confidentiality, I have obfuscated 
all the “sensitive subjects” in this thesis, while still tried to maintain the text as 
understandable as possible. 
In the beginning of September 2010, there were some uncertainties about me getting 
the thesis work in the company, mainly as the thesis subject was not directly related to 
my work responsibilities in the company. I would like to thank Ramin and Riikka, 
who granted me this chance and made all this possible. Especially, I would like to 
give my greatest gratitude to Riikka, who had guided me through all this work and 
selflessly devoted some of her private hours and family time to revise my thesis. Also 
I would like to thank Mikko for offering me helpful comments on my practical work 
and my girlfriend Jue for supporting me during the whole of this work. Lastly I would 
like to give my heartfelt thanks to Prof. Jukka Manner for the final review of my 
thesis. 
 
Helsinki, 30th August 2011 
Zhishuai Yao
  iv 
Contents	  
1	   Introduction	  .................................................................................................................	  1	  
1.1	   Background ..................................................................................................................... 1	  
1.2	   Objectives ........................................................................................................................ 2	  
1.3	   Outlines of the Thesis ...................................................................................................... 2	  
2	   Radiation	  Therapy	  in	  General	  ................................................................................	  4	  
2.1	   Basics of Cancer Treatment ............................................................................................ 4	  
2.1.1	   Surgery in Cancer Treatment .................................................................................. 4	  
2.1.2	   Chemotherapy in Cancer Treatment ....................................................................... 4	  
2.1.3	   Radiation Therapy in Cancer Treatment ................................................................. 5	  
2.2	   Basics of Radiation Therapy ........................................................................................... 6	  
2.3	   Types of Radiation in Cancer Treatment ........................................................................ 7	  
2.3.1	   External Beam Radiation Therapy .......................................................................... 8	  
2.3.2	   Brachytherapy ......................................................................................................... 9	  
2.4	   Linear Accelerator ......................................................................................................... 10	  
2.4.1	   Gantry .................................................................................................................... 11	  
2.4.2	   Gamma Ray Target ................................................................................................ 12	  
2.4.3	   Primary Collimator ............................................................................................... 13	  
2.4.4	   Flattening Filter .................................................................................................... 13	  
2.4.5	   Beam Monitor ........................................................................................................ 14	  
2.4.6	   Moveable Beam Defining Collimators .................................................................. 15	  
2.4.7	   Block ...................................................................................................................... 16	  
2.4.8	   Multileaf Collimator .............................................................................................. 18	  
2.4.9	   Wedge Filter .......................................................................................................... 18	  
2.4.10	   Patient Support System .......................................................................................... 21	  
3	   Clinical	  Radiation	  Therapy	  Workflow	  ..............................................................	  22	  
3.1	   Clinical Staffing of Radiation Therapy ......................................................................... 22	  
3.1.1	   Radiation Oncologists ........................................................................................... 22	  
3.1.2	   Radiation Medical Physicists ................................................................................ 23	  
3.1.3	   Radiation therapists ............................................................................................... 24	  
3.1.4	   Dosimetrists ........................................................................................................... 24	  
3.1.5	   Radiation Oncology Nurses ................................................................................... 24	  
3.2	   General Workflow for Radiation Therapy .................................................................... 24	  
3.2.1	   Initial Consultation ................................................................................................ 25	  
3.2.2	   Virtual Simulation .................................................................................................. 25	  
3.2.3	   Treatment Planning ............................................................................................... 26	  
3.2.4	   Pre-treatment Verification ..................................................................................... 27	  
3.2.5	   Daily Treatments ................................................................................................... 27	  
3.2.6	   Patient Follow-ups ................................................................................................ 27	  
4	   Treatment	  Planning	  System	  ................................................................................	  28	  
4.1	   Overview of Computerized Treatment Planning System .............................................. 28	  
4.1.1	   Beam Data ............................................................................................................. 28	  
  v 
4.1.2	   Input of Patient Image Data .................................................................................. 29	  
4.1.3	   Input of Treatment Parameters .............................................................................. 30	  
4.1.4	   Treatment Plan Visualization and Output ............................................................. 30	  
4.1.5	   Optimization .......................................................................................................... 30	  
4.2	   Treatment Planning Process Based on TPS .................................................................. 31	  
4.2.1	   Patient Identification and Image Preparation ....................................................... 31	  
4.2.2	   Image Segmentation .............................................................................................. 31	  
4.2.3	   Plan Setup .............................................................................................................. 32	  
4.2.4	   Dose Calculation and Plan Evaluation ................................................................. 32	  
4.2.5	   Treatment Plan Approval ...................................................................................... 32	  
5	   Risk	  Management	  for	  Medical	  Devices	  ............................................................	  33	  
5.1	   Risk Management .......................................................................................................... 33	  
5.1.1	   Risk Management Process ..................................................................................... 34	  
5.1.2	   Risk Analysis .......................................................................................................... 35	  
5.1.3	   Risk Evaluation ...................................................................................................... 35	  
5.1.4	   Risk Control ........................................................................................................... 36	  
5.1.5	   Evaluation of Overall Residual Risk Acceptability ............................................... 37	  
5.1.6	   Risk Management Report ....................................................................................... 37	  
5.1.7	   Production and Post-production information ....................................................... 37	  
5.2	   Risks Associated to Treatment Planning System .......................................................... 38	  
6	   Software	  Testing	  ......................................................................................................	  39	  
6.1	   Basics of Software Development Life Cycle Models ................................................... 39	  
6.1.1	   Spiral Development Model .................................................................................... 40	  
6.1.2	   Test-driven Development Model ............................................................................ 42	  
6.2	   Software Testing Terms and Definitions ...................................................................... 42	  
6.2.1	   Verification and Validation ................................................................................... 42	  
6.2.2	   Quality and Reliability ........................................................................................... 43	  
6.2.3	   Testing and Quality Assurance .............................................................................. 43	  
6.3	   Basic Taxonomy of Software Testing Techniques ....................................................... 44	  
6.3.1	   White Box Testing and Black Box Testing ............................................................. 44	  
6.3.2	   Unit Testing and Integration Testing ..................................................................... 44	  
6.3.3	   Regression Testing ................................................................................................. 44	  
6.3.4	   Automated Testing ................................................................................................. 45	  
7	   Automated	  Testing	  Tool	  CppUnit	  ......................................................................	  46	  
7.1	   Background of CppUnit ................................................................................................ 46	  
7.2	   Architecture of CppUnit ................................................................................................ 46	  
7.2.1	   The Key Test Classes ............................................................................................. 48	  
7.2.2	   Test Results Collection Classes ............................................................................. 49	  
7.2.3	   Test Output Classes ............................................................................................... 50	  
8	   Implementations	  .....................................................................................................	  51	  
8.1	   Goals .............................................................................................................................. 51	  
8.2	   Design ............................................................................................................................ 51	  
8.2.1	   Test Procedure ....................................................................................................... 52	  
  vi 
8.2.2	   Other Features of the Test ..................................................................................... 54	  
9	   Evaluation	  ..................................................................................................................	  56	  
9.1	   Test Acceptance Criteria ............................................................................................... 56	  
9.2	   Test Result Summary .................................................................................................... 56	  
10	   Conclusions	  ...........................................................................................................	  59	  
Bibliography	  .....................................................................................................................	  60	  
 
   
Abbreviations	  
 
3D Three Dimension 
ALARP As low as reasonably practicable 
CT Computed Tomography 
DICOM Digital Imaging and Communication in Medicine 
DNA Deoxyribonucleic Acid 
FDA U.S Food and Drug Administration 
IAEC The International Association of Elevator Consultants 
ICRU Internationalization Commission on Radiation Units and Measurements 
ID Identification 
IDE  Integrated Development Environment 
MFC  Microsoft Foundation Class 
MLC Multileaf Collimator 
MRI Magnetic Resonance Image 
RNA Ribonucleic Acid 
RT Radiation Therapy 
STL Standard Template Library 
TPS Treatment Planning System 
XML Extensible Markup Language 
 
 
   
1 Introduction 
1.1 Background	  
Most basically, cancer is the term for diseases in which a group of previously normal 
cells have gone through a serial genetic alteration in their DNAs and eventually 
appear uncontrolled self growing, infectiveness to surrounding tissues and capability 
of spreading to other places of the body [1]. Clinically, this group of cells is termed as 
malignant tumor. Other than cancer cells, there is another group of cells that tend to 
be less harmful. They can form a tumor that is self-limited and constrained to one 
single location; it’s so called benign tumor. Benign tumor is only dangerous when it 
begins to compress other normal tissues.  
According to the statistic data from American Cancer Society, in 2009 there were 
more than 292,540 male plus 269,800 female died from cancer in the US [2]. With all 
the new technologies and methodologies introduced to the cancer treatments, the 
death rate of cancer has dropped 16% in the period of 1991 to 2006. Nevertheless, 
cancer is still ranked the second man-killer among other diseases1 and it is estimated 
today that just few years from now, the death toll from cancer will exceed that from 
cardiovascular disease [2,3]. 
Nowadays there are three major therapeutic methods to treat cancers, which are 
surgical operation, chemotherapy and radiation therapy. In radiation therapy, 
treatment has a very low tolerance level for inaccuracies and errors, since the high 
proportion of body is under exposure of high-energy radiation. If mistreatment 
happens, it is very likely to cause a serious injure or even death to the patient. 
Therefore, radiation device manufacturers and clinics have been making actions on 
                                                        
1 It is slightly after cardiovascular diseases. 
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eliminating mistreatments through risk management and quality assurance. 
1.2 Objectives	  
In this work, automated tests are developed for verifying a large set of checking 
functions executed in a computerized treatment planning system (TPS) software for 
radiation therapy. In order to protect the target company’s confidentiality, the term 
“checking functions” will be used to represent the testing subject throughout this 
thesis, and the content or the purpose of the checking functions will not be specified 
in more detail. The essential is that the checking functions will trigger error or 
warning message shown to the user, if they detect a case that violate the pre-defined 
rule. 
The objective of implementing these automated tests is to generate these cases which 
violate specific rules in order to check whether the expected error or warning message 
is thrown by the checking functions and is correctly shown to the user. Especially, the 
automated tests should be able to trigger the violation cases that are not possible to be 
generated from graphic user interface, but requires e.g. internal system failures or data 
corruptions. In addition, as part of the regression tests, these automated tests should 
reduce the time needed for testing and should be able to be executed at any phase of 
the product development so that possible defects can be found immediately after it 
occurs. 
1.3 Outlines	  of	  the	  Thesis	  
In Chapter 2, the operational principle of radiation therapy is presented in order to 
introduce the basic concept of radiation therapy in cancer treatment. Afterwards, 
several techniques that are used in radiation therapy are discussed in general. After 
introducing the background, Chapter 3 presents the common staffing and workflow of 
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radiation therapy in clinics. In Chapter 4, in addition to provide an overview of 
computerized treatment planning system, general process of treatment planning using 
TPS is discussed. Chapter 5 focuses on explaining the risk management in radiation 
therapy. Chapter 6 and 7 mainly discuss about the required background knowledge of 
this work, which includes the knowledge of software testing and the testing tool 
(CppUnit) used in this work. In Chapter 8, the actual work is presented. It reveals the 
concept of the design of the implementation. Chapter 9 evaluates the testing results 
generated from the developed test cases. Conclusion of this work is made in Chapter 
10, as well as a future sight to this subject. 
   
2 Radiation Therapy in General 
In this chapter, the general knowledge of radiation therapy will be presented. The 
focus is on the external beam radiation therapy, which is considered to be the most 
popular treatment method in radiation therapy. 
2.1 Basics	  of	  Cancer	  Treatment	  
In cancer treatments, there are three major standard methods for treating cancers: 
surgery, chemotherapy and radiation therapy. Each of these methods is eligible to be 
used alone in one treatment; it is called single-method therapy. More often, more than 
one method is carried out to one treatment, which is termed as multi- method therapy 
[4]. 
2.1.1 Surgery	  in	  Cancer	  Treatment	  
In cancer treatment, surgery belongs to the category of local treatment, which requires 
accurate positioning to the target - the malignant tumor. After tumor being located, 
most but not entire tumor will be removed surgically, while affected organs’ 
functionalities are tent to be preserved utmost. The rest remained tumor tissues will be 
treated by other means afterwards, e.g. chemotherapy or radiation therapy. Usually, 
the outcomes of the surgical operation will come along with certain side effects 
because malignant organs have been removed partially or entirely, which will 
negatively affect patients’ quality of lives. Thus, the decision to undergo this kind of 
treatment is difficult for the patients [4]. 
2.1.2 Chemotherapy	  in	  Cancer	  Treatment	  
Chemotherapy is a systemic treatment for which medications travel through the 
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bloodstream and act against the rapidly dividing cells [5]. The principle is that cancer 
cell shares the common characteristic of rapid self-dividing. This feature makes the 
cancer cells become vulnerable to the chemotherapeutic medications. By taking 
advantage of this fact, cancer cells can be eliminated most effectively by medications, 
whereas other normal cells are affected less [5]. 
In the treatment of chemotherapy, drugs or medications are given in different 
schedules [5]. In general, chemotherapy is administered in cycles of every three to 
four weeks [4]. Within a cycle, patients will be medicated for one or two weeks. After 
then, they will be allowed to have another one or two weeks time to recover from the 
previous treatment and prepare for the next one [5]. 
Because chemotherapy is aimed at damaging the cells that are rapidly dividing, some 
normal cells that share the same feature will also be affected. For example, stem cells, 
hair cells and blood cells. Common side effects such as hair loss and nausea may 
happen for this reason [4,5]. Therefore, chemotherapy treatment schedule should be 
carefully designed to allow the normal cells sufficient time to recover, while repeating 
the treatments frequently enough so that the cancer cells do not recover [4]. 
2.1.3 Radiation	  Therapy	  in	  Cancer	  Treatment	  
Radiation therapy as a cancer treatment method is considered as a great revolution in 
the history of medicine. It uses high-energy ionizing radiation to disrupt the cellular 
dividing, which will ultimately cause the death of the cancer cells [6]. 
Radiation therapy is also categorized as local treatment because only the cells in and 
around tumor will be treated or radiated. However, it is unavoidable that the 
high-energy beams will cause some damage to the normal cells when beams are 
passing through the body from the surface of the skin to the malignant tumors. This 
will cause some side effects, which may be seen after weeks, months or years [7]. 
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Among all these three major standard methods of cancer treatments, radiation therapy 
is the one that will be discussed in more detail in the following chapters. 
2.2 Basics	  of	  Radiation	  Therapy	  
Radiation therapy uses high-energy ionizing radiation to cause serials of biological 
effects in cancer cells, which are largely the result of their DNA damage [7]. To 
understand how the radiation therapy works, it is helpful to know about the life cycle 
of the cell [8]. 
As it shows in Figure 2.1, the cell life cycle is a sequence of highly ordered process 
which consists of four phases: G1, S, G2, and M, for representing different states of 
the cell. Cells that are newly generated are first born into G1 phase [6]. In this phase, 
cells start producing more proteins for preparing cells’ dividing. At the same time, 
single strands of DNA, so called RNA are also made. After entering S phase, the 
DNA synthesis occurs and two copies of each chromosome are produced. In the G2 
phase, cells continue to grow and prepare for the mitosis, or division of the cell 
nucleus. M phase is the final operational phase for cell diving, in which the duplicated 
chromosomes will be separated into single chromosome and cells will split into two at 
the end of the M phase [6,7,8]. In addition, cells may go to a special resting phase, G0 
phase, in which cell cycle is partially dismantled. When these cells get certain signal, 
they will enter into G1 phase and start cycling again [6]. 
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Figure 2.1 The cell life cycle [8] 
The speed of the cell life cycle affects the effectiveness of ionizing radiation killing 
cancer cells. Radiation kills cancer cells because they are dividing quickly and 
growing out of control. In contrary, the cells in G0 phase or dividing slowly are less 
sensitive to the radiation exposures. When the patient’s tumor is under radiation, the 
cancer cells’ DNA is tent to be damaged biologically so that the cells dividing 
mechanism can be disrupted. This damage will eventually lead to cancer cells’ dying 
in days or weeks. As discussed before, even though radiation therapy is categorized as 
local treatment and radiation aims directly at the malignant tumor, it is inevitable that 
the normal tissue around the tumor will also be radiated and this will cause some side 
effects. Cells in tissues such as skin and bone marrow are also growing and dividing 
relatively faster than other normal cells, thus they are always affected immediately 
after the treatment. In contrast, cells in bone, nerve, and breast tissue always show 
later effects [7]. Therefore, the goal of radiation therapy is to maximize the dose to 
malignant tumor while minimizing exposure to normal, healthy cells. 
2.3 Types	  of	  Radiation	  in	  Cancer	  Treatment	  
Radiation therapy can be classified into two different types based on the positioning 
of the radioactive source: external beam radiation therapy and internal radiation 
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therapy or brachytherapy. 
2.3.1 External	  Beam	  Radiation	  Therapy	  
External beam radiation therapy is the most common form of the radiation therapy. In 
general, external beam radiation therapy consists of a beam (or multiple beams) of 
ionizing radiation such as high-energy photon beams (gamma rays), electron beams or 
proton beams that are all generated outside the patient and are targeted at the tumor 
site to destroy cancer cells or slow their rate of growth [9]. 
2.3.1.1 Photon	  Beam	  Therapy	  
Photon beam therapy is the most used treatment modality in external beam radiation 
therapy. There are two general methods to create photon beams. Firstly, photon beams 
can be released from various types of radioactive source. One of the common sources 
is cobalt 60, which is used to generate photon beams that can be also categorized as 
gamma rays. In the middle of 20th century, cobalt 60 source was first implemented in 
a cobalt unit for clinical use. A typical size of a cobalt 60 source is with diameter 2cm 
and height 5cm [10]. The cobalt unit uses collimator jaws only to control the time and 
the strength of the radiation treatment. This feature is one of the constraints that have 
limited the range of the usage of cobalt machine, comparing to the linear accelerator, 
which is the other type of unit that can provide gamma ray photon beams. This is 
done, by having high-speed electrons that are accelerated by high frequency 
electromagnetic waves, striking to the target source [10]. No matter through which 
type of sources and methods that the photon beams are created, the physiology and 
biology effects of the different photon beams are equivalent. 
2.3.1.2 Electron	  Beam	  Therapy	  
Linear accelerator can produce not only gamma rays, but also can emit electrons itself 
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to form the treatment beams. With the advent of the high-energy linear accelerators, 
electron beam therapy has become an important option in treating superficial tumors 
[11]. The reason for this is that electron beam therapy has a significant advantage at 
delivering a reasonably uniform dose from the surface to a specific depth, after which 
dose falls rapidly. This character allows it to treat certain superficial tumors, such as 
skin and lips cancer, which are up to depth of about 5 cm. 
2.3.1.3 Proton	  Beam	  Therapy	  	  
Proton beam is a form of particle beam. Comparing with conventional external beam 
radiation, such as photon beam and electron beam radiation, proton beam is more 
capable at precisely localizing the radiation dosage. This is because of that proton 
beams are formed by particles that have relatively large mass, which makes it possible 
to limit the lateral side scatter in the normal tissue when beams are passing through 
and cause great damage at the end of the beams’ path [12]. This also means proton 
beam radiation therapy can administrate greater dose to the tumor, however has less 
side effect to the normal tissues nearby [7]. 
2.3.2 Brachytherapy	  
Brachytherapy is an internal radiation therapy that places radioactive materials inside 
the tumor or beside the tumor. It provides another way to take advantage of human 
cells’ biological effect while under radiation [13]. In contrast to external beam 
radiation therapy in which beams will go through the body toward the tumor, 
radiation of brachytherapy affects a more localized area around the radiation source. 
In such case, normal tissues can be better preserved. More often, brachytherapy is 
used along with other treatments for cancer such as surgery and chemotherapy.  
To move the radioactive source into patient’s body, shielded hollow tube (catheter) or 
applicator are commonly used, together with a loading device called afterloader 
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machine. This technology provides a protection to the operator and patients from the 
risk of unnecessary radiation. When the treatment plan is completed, afterloader 
machine moves the radioactive source through the applicator and stops the source in 
the planned position for a defined time. Finally, tumor tissues around those 
radioactive sources are damaged or killed by the radiation.  
There are two major types of brachytherapy, classified according to the duration of 
the dose delivery [14]: 
• Permanent Implant: In permanent implant, several radioactive pellets, so 
called seeds, are implanted inside the tumor permanently. The seeds will give 
off a known amount of radiation. After a certain period, there will be no 
measurable radiation inside or outside the body. Before the seeds become 
nonradioactive, patients have to follow the safety precautions after seeds are 
implemented. 
• Removable Implant: As the name suggests, radioactive source will be 
implanted in patient’s body temporarily for removable implant. The treatment 
period could vary from few minutes to days depending on many different 
factors, such as, tumor type, size and location. In low-dose-rate brachytherapy, 
radioactive seed will be administered in patient’s body up to 24 hours before 
being removed. In contrast, high-dose-rate brachytherapy allows radioactive 
seed to give a high dose rate to the target area in few minutes. 
2.4 Linear	  Accelerator	  
In general usage, radiation treatment machine is referred as a whole system that is 
used for delivering radiation therapy. It includes beam production system, waveguide 
and beam transferring system, cooling system, treatment head and beam defining 
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system and patient support system. In this thesis, the terminology of radiation 
treatment machine is only defined for linear accelerator treatment head, beam defining 
system, and patient support system. Only those components of the system will be 
discussed in this chapter [15]. 
In radiation treatment machines, the linear accelerator treatment head can be 
categorized into two kinds, either being in line with the waveguide or at right angle 
with the waveguide. For the convenience of the implementation at the clinics, the 
treatment head is always mounted vertically to the waveguide. Additionally a 
beam-bending magnet is required at the end of the waveguide to bend the beam to 
right angle. 
2.4.1 Gantry	  
Nowadays, most of the treatment head is constructed in such a way that the source of 
the radiation beam can be rotated around horizontal axis as shown in Figure 2.2. 
While the gantry rotates, the collimator axis (central axis of radiation beam) moves in 
a circle around a central point, which is known as isocenter. 
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Figure 2.2: Photograph of a linear accelerator [16] 
2.4.2 Gamma	  Ray	  Target	  
In Figure 2.3, a target source is placed at the upper edge of the treatment head. As has 
been mentioned in 2.3.1.1, this target source is used to emit photon beams by having 
high-speed electrons strike to it. This beam transmission process will also generate 
significant heat, which could affect the physical performance of the machine. In order 
to address this problem, a flowing-water cooling system is used to take away the 
operating heat constantly when linear accelerator is emitting radiation beams. 
However, this is not presented in the Figure 2.3. 
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Figure 2.3: The treatment head for the treatment machine [15]. 
2.4.3 Primary	  Collimator	  
Primary collimator is mounted at the starting point of the photon beam. This element 
controls the maximum field size for treatments. In order to provide a sufficient 
attenuation rate, primary collimator is usually made of lead that filled with steel or 
heavy metals. 
2.4.4 Flattening	  Filter	  
The photon beam that first comes out of the primary collimator is initially not 
flattened and has a sharp peak dose distribution along the central axis of the beam. 
The higher the electron energy is used, the steeper the curve is. 
Flattening filter is used to attenuate the peak dose at the beam’s central axis and to 
provide a uniform dose distribution. Figure 2.4 shows the relative dose measured 1 
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meter away from the source target at the plane perpendicular to central axis. 
It is worth to mention that the clinical usage of the flattening filter is quite strict. A 
minor movement of the flattening filter will make an otherwise flattened beam 
un-flattened and asymmetrical. Therefore, the mechanical installation is critical [15]. 
Besides, different photon beam energies will require different flattening filters. 
Nowadays, most of the linear accelerators support more than one beam energies, so 
that the same amount of flattening filter should be mounted and well matched with the 
energies. Lastly, using a flattening filter with an unstable energy will also cause an 
unexpected dose distribution. This factor shall be controlled by beam monitoring 
system, which will be discussed in next section. 
 
Figure 2.4: Measured dose distribution 1 meter away from the source target at the plan perpendicular to central 
axis. Curve A shows the 8MV photon beam without flattening filter; Curve B shows the 8MV photon beam with 
flattening filter and Curve C shows the 20MV photon beam without flattening filter [15]. 
2.4.5 Beam	  Monitor	  
The beam monitoring system consists of several transmission ionization chambers or 
a single chamber with multiple plates. The usage of ionization chamber is to monitor 
dose rate, integrated dose and field symmetry. Since the beam monitoring system is 
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under high-energy radiation, it is important to make sure the efficiency of ion 
collection. In order to preserve the accuracy of the measurement, there are three 
general requirements [15]: 
• It should be thin. 
• Its ionization sensitivity should be independent to ambient temperature and 
pressure. 
• It should be operated under saturation conditions. 
Beam monitor chamber has to be so thin that the thickness would not cause too much 
perturbation to the treatment beam. Normally, the ionization chamber consists of 
multiple parallel plates. Each plate is typically 0.1 mm thick. To maintain the constant 
sensitivity of beam monitoring system, monitor chamber is usually sealed to prevent 
the influences from the variation of ambient temperature and pressure. However, 
these chambers have to be periodically checked for leaks [15]. 
2.4.6 Moveable	  Beam	  Defining	  Collimators	  
The movable beam defining collimators are usually made of lead or tungsten and are 
operated in two pairs, which can shape the photon beam from two orthogonal 
directions [15]. In order to provide more capability for shaping, collimators are 
usually installed within a rotating frame in addition, which allows it to rotate in 
horizontal axis. 
Generally, there are two major types of beam defining collimators, which are 
symmetric collimators and asymmetric collimators. 
• Symmetric collimators: This kind of beam defining collimators is inherited 
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from old fashion treatment machines. Two pairs of collimators are only 
allowed to operate in symmetric manner [15]. 
• Asymmetric collimators: This kind of collimators allows each pair jaw to 
operate independently, which provides more flexibility on blocking the beam. 
To be more detailed, asymmetric collimators allow single jaw to move across 
the central axis by up to 10 to 15 cm or even more, so that collimators are 
capable to block one-half or three-quarters of the field where the beam edges 
are coincident with the central axis. Placing such kind of blocked field in 
different directions, allows reducing the divergences of the beams [15]. 
2.4.7 Block	  
A major constraint in the radiation therapy is the limitation of the highest dose that 
can be delivered to the tumor because of the dose tolerance of other normal tissues 
surrounding or near the tumor site [17]. Shielding within a radiation field is one of the 
primary methods that allows oncologist to increase the dose to the tumor volume 
while sparing the other tissues. The main purposes of shielding can be summarized in 
three: 
• To protect vital organs from radiation. 
• To avoid unnecessary irradiation to surrounding normal tissues. 
• To match adjacent fields. 
In classic radiation treatment, shielding blocks are commonly used. It is usually made 
of lead and has an inner outline of the radiation target shape. The thickness of the lead 
required to provide adequate radiation attenuation to the shielded areas are very much 
depending on the beam energy and allowed transmission through the block. Normally, 
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a transmission rate below 5% of the initial radiation is accepted. 
The frequency and complexity of field shielding vary from site to site in clinics. In 
some institutions, where field shielding is more often used, a custom blocking system 
could be implemented. In this technique, a special material called Lipowitz metal 
(brand name, Correobend) is used. This material consists of 50.0% bismuth, 26.7% 
lead, 13.3% tin, and 10.0% cadmium, and has a merit that it melts at about 70 degree, 
whereas lead melts at about 327 degree [16]. Therefore, Lipowitz metal can be easily 
cast into any shapes. In Figure 2.5, it shows a Styrofoam-cutting device, which 
consists of an electronic heated wire that used to simulate the casting of Lipowitz 
metal. 
 
Figure 2.5: Photograph of block cutter. (Courtesy of Huestis Machine Corp., Bristol, RI.) [16] 
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2.4.8 Multileaf	  Collimator	  
Multileaf collimator (MLC), first introduced in Japan in the 1960s, has now been 
rapidly deployed in clinics as a replacement of block shaping [17]. MLC serves an 
alternative to shape the beam in irregular shapes other than rectangular as discussed in 
2.4.6. This feature allows a further dose minimization to the normal tissues 
surrounding or nearby the tumor. Furthermore, some radiation treatments are planned 
to use multiple fields to treat cancers from different angles, in which MLC can be 
used to automatically shape the beams according to target volume’s outline. This 
feature has been specified as a substantial requirement for some treatment machines. 
Figure 2.6 is a simplified diagram of a multileaf collimator with two opposing banks 
of attenuating leaves [15]. Each leaf can be positioned independently by a computer 
controlling system that also determines the precision of the leaf positioning (usually 
better than 1mm). 
 
Figure 2.6: Simplified diagram of an MLC [15]. 
2.4.9 Wedge	  Filter	  
Wedge filter is one of the most commonly used beam modifying devices that are used 
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for modifying the isodose distribution. Originally, the wedge filter is usually made of 
metal and has a wedged shape, as its name implies [16]. It is this particular shape that 
causes a progressive decrease of the radiation in the intensity across the flattened 
beam and results in a gradient isodose curve as shown in Figure 2.7 [17]. 
 
Figure 2.7: Isodose distributions for a 6MV photon beam with an 8x8cm field size. Graph a. refers to open field; 
Graph b. refers to field with a 45 degree wedge [17]. 
There are several reasons for using wedge filter to generate gradient isodose 
distribution. The most important one is to achieve a uniformed dose distribution 
throughout a target volume by combining multiple fields that use wedge filter. There 
are three variants of the wedge filters in general [16]: 
• Individual Removable Wedge Filter: This kind of wedge is designed 
individually for certain beam width with a specified tilted angle. Each kind of 
individual wedge filter is only capable to form a particular isodose line. 
• Universal or Motorized Wedge Filter: Universal or motorized wedge filter is a 
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single wedge filter that is designed to serve all beam widths by placing it at the 
center of the beam while the field can be opened to any size. A simple usage 
of motorized wedge filter is illustrated in Figure 2.8. 
 
Figure 2.8: Schematic representation of A an individualized wedge for a specific field width in which the thin 
end of the wedge is always aligned with the field border and B a universal wedge in which the center of the 
wedge filter is fixed at the beam axis and the field can be opened to any width [16]. 
• Dynamic Wedge Filter: Dynamic wedge filter is not actually a physical wedge 
filter; instead, it is a term to describe the production of a wedged beam profile 
by dynamically adjusting the independent collimator jaw within treatment 
beam. A simple usage of dynamic wedge filter is illustrated in Figure 2.9. 
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Figure 2.9: Use of the collimator to produce a dynamic wedge [15]. 
2.4.10 Patient	  Support	  System	  
Patient support system is also referred as treatment couch on which patient will be 
placed during the radiation treatment. Treatment couch can rotate around the vertical 
axis, which gives a way to avoid or reduce the radiation to some critical normal 
tissues around the tumor while it is being radiated. Furthermore, treatment couch can 
also move in horizontal space in order to place the isocenter precisely inside the tumor 
for treatment.
   
3 Clinical Radiation Therapy Workflow 
The radiation therapy treatment is a very sophisticated process. Each hospital or clinic 
may adopt its own infrastructure and workflow to realize the final delivery of the dose 
to patients. In this chapter, general background information about radiation therapy 
clinical stuffing and workflow will be discussed in order to indicate a typical 
treatment process. 
3.1 Clinical	  Staffing	  of	  Radiation	  Therapy	  
In this section, the clinical personnel placement of radiation therapy recommended by 
International Atomic Energy Agency (IAEC) will be discussed [18]. 
3.1.1 Radiation	  Oncologists	  
Radiation Oncologists are physicians who have special expertise in the therapeutic 
applications of ionizing radiation. They shall have a comprehensive understanding of 
the biological effect of the interaction of radiation with human tissues. Additionally, 
radiation oncologists shall also have knowledge about the causes, preventions and 
treatments of cancers and other diseases [19]. 
In the aspect of the oncology department, radiation oncologists are responsible for 
setting up the overall treatment policy for radiation therapy, which includes designing 
the clinical facilities. For single patients, radiation oncologist is responsible for 
verifying the diagnosis, defining the target volume, specifying radiation doses, and 
determining the objectives of radiation treatment plan that includes setting limitations 
on doses to critical structures [18]. 
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3.1.2 Radiation	  Medical	  Physicists	  
Persons who are specialized in radiation therapy physics will be referred as radiation 
physicists. Their responsibilities can be classified as following five points [19]: 
• Dosimetry: Radiation physicists should help to reduce the probability of 
unintentional radiation injuries. To achieve this, radiation physicists are 
dedicated to calibrate the treatment machine on routine basis and ensure the 
output data of the treatment machine are accurate and adequate to use 
clinically. 
• Radiation safety: Radiation physicists are also required to design a radiation 
protection program to ensure the safeness of clinic stuff and other public 
persons. 
• Treatment planning: Radiation physicist is responsible for the generation of 
possible treatment plans and should concern the consistency of the 
prescriptions through similar patients, and any founded inconsistency should 
be discussed with radiation oncologists. In addition, radiation physicists 
should also be aware of the critical body structures, and consider the 
limitations on radiation dose together with radiation oncologists. 
• Quality control: Radiation physicists are involved in establishing and 
operating the quality control program in clinics. 
• Equipment selection: Radiation physicists will work together with radiation 
oncologists to determine the clinical needs for treatment equipment. 
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3.1.3 Radiation	  therapists	  
The obligations for radiation therapists are spread widely in different clinics. The 
most common tasks for radiation therapists are as following [18]: 
• Operating treatment machines 
• Operating simulators and imaging devices 
• Producing immobilization devices, like face masks 
It is worth to mention that in the daily treatment, radiation therapists are more 
frequently being aside with patients than radiation oncologists are. Therefore, a 
favorable relationship is strongly encouraged between radiation therapist and patient, 
so that early warnings and unusual symptoms can be discovered. 
3.1.4 Dosimetrists	  
Dosimetrists are radiation therapists who are specially trained in radiation dosimetry 
[18]. Their primary obligation is to calculate radiation dose by using computerized 
treatment planning system, which will be discussed in Chapter 4. 
3.1.5 Radiation	  Oncology	  Nurses	  
Radiation oncology nurses are responsible for taking care of patients undergoing 
treatment. This task also needs appropriate trainings [18].  
3.2 General	  Workflow	  for	  Radiation	  Therapy	  
This section is based on the analysis of the workflows of multiple radiotherapy clinics 
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as presented in their web sites. Those clinics are Advanced Radiation Center of New 
York [20], Abramson Cancer Center of University of Pennsylvania [21], Mayo 
Clinic [22] and Vassar Brothers Medical Center [23]. 
3.2.1 Initial	  Consultation	  
Whenever radiation therapy is being determined as part of cancer patient’s treatment 
strategy, an appointment has to be made with radiation oncologists. In this 
appointment, radiation oncologists will review patient current case and health history; 
also, an examination may be carried out after or before the appointment, if necessary 
[20]. Additionally, the role of the radiation therapy for individual patient will be 
defined; and the specific radiation modality (see Section 2.3) may be determined. 
During this consultation, patients will receive an estimated prescription and 
information about possible side effects. They may also ask any questions related to 
the treatment [20]. 
3.2.2 Virtual	  Simulation	  
The virtual simulation phase is where all the necessary image information that the 
radiation oncologists need to create an individualized radiation course for patient is 
gathered [21]. In the clinics, dedicated CT scanners, known as CT-simulators, are 
used to construct patient CT images [24]. Figure 3.1 is a CT-simulator that is used in 
the clinics, which has a laser light on the side to help positioning the patient [25]. 
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Figure 3.1 CT-simulator used in Hunterdon Healthcare Clinic [25]. 
The virtual simulation session normally takes about 30 to 60 minutes, in which 
measurements of patient body are taken and CT scan of the treated region is taken. 
The information of the scanned CT images is essential for precisely locating the 
patient tumor and positioning the treatment field in the real treatment phase [24]. At 
the end of the virtual simulation, it is usual to put small tattoo or ink marker on 
patient’s body to aid at daily treatment set-up reproducibility [21]. In certain types of 
radiation treatment, special patient fixation devices are used to ensure that patient will 
be placed in the exactly the same location in the treatment room as in virtual 
simulation room [22]. This step further guarantees tumor volume is going to be 
treated as planed in CT images. 
3.2.3 Treatment	  Planning	  
After patient leaves the virtual simulation room, radiation oncologists, together with 
radiation physicists and medical radiation dosimetrists will carefully examine 
patient’s anatomy images and relevant information during the treatment planning 
phase [20]. With the assist of sophisticated computerized treatment planning systems 
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(see Chapter 4), the properties of the radiation beams can be settled, and most 
importantly, patient’s dosimetric information is calculated by using state-of-art 
mathematical algorithms [20]. 
3.2.4 Pre-­‐treatment	  Verification	  
In some clinics, patient will be taken to the real treatment room on day one for a 
pre-treatment verification after all the planning and calculation is done [20]. In this 
phase, actual treatment will not be administered. Patient will only go through all the 
procedures of the real plan, and instead of receiving the real radiation dose, patient 
films will be taken for reviewing by the radiation oncologists to confirm and verify 
the treatment plan. In this phase, any fine-tuning of the planning can be made prior to 
treatment. 
3.2.5 Daily	  Treatments	  
In the next phase, patient will usually be scheduled to visit clinic once a day, from 
Monday to Friday, for several weeks. The radiation treatment will be delivered after 
positioning the patient precisely on the treatment couch. Generally, each treatment 
will take 5 to 10 minutes, depending on how sophisticated the plan is (e.g. number of 
radiation fields, used accessories, and etc.) [21]. 
3.2.6 Patient	  Follow-­‐ups	  
Once the radiation therapy is completed, patient will be asked to have a follow-up 
visit to radiation oncologists after 2 to 6 weeks [21]. The purpose of the visit is to 
assess the patient response to treatment and the status of the cancer. It helps to 
identify the complications as early as possible [23].
   
4 Treatment Planning System 
Treatment planning system is a computerized medical system that is used to simulate 
the application of radiation to a patient for a purpose of radiation therapy [26]. In this 
chapter, the basic components of the treatment planning system and its typical process 
used in the clinical will be discussed. 
4.1 Overview	   of	   Computerized	   Treatment	   Planning	  
System	  
Nowadays TPS has been broadly used in oncology departments in many hospitals. 
The installation and specific functionalities of TPS in oncology departments can vary 
slightly from site to site. However, the general usages are similar, including viewing 
RT images, defining tumors and other critical structures, setting up fields, simulating 
radiation treatments, calculating dose, and evaluating plans [27]. All these features of 
TPS serve as a way of generating the virtualized beam shapes and dose distributions 
with the intention to help clinicians to maximize the tumor control and minimize the 
normal tissue complications for the patient. 
According to the recommendations from ICRU Report 422 [27], there are several 
practical aspects for a computerized treatment planning system to follow. 
4.1.1 Beam	  Data	  
Beam data is set of real dosimetric data that is measured and calculated from a water 
phantom for a specific clinical treatment machine. This kind of data is used as 
simulation data for dose calculation algorithms to generate the realistic dose 
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distribution in a clinical case. 
Acquisition of beam data and building up beam data library are always the first two 
steps in the procedure of using a computerized treatment planning systems. They are 
essential tasks that need to be completed only when a new treatment machine is 
installed or when some basic changes are made to the machine, for instance 
modification to the angle of wedge filter or size changing of primary collimator. After 
beam data has been acquired and configured, the validity of the entire beam data shall 
be closely checked before using for clinical purposes [27]. 
4.1.2 Input	  of	  Patient	  Image	  Data	  
Patient image data is the other set of data that is needed for computerized treatment 
planning systems [27], besides beam data. By combining the radiation beam 
characteristics and the patient image data, treatment planning system can produce 
dose distribution throughout the target volume and nearby tissues. 
Creating a patient image data for the use of treatment planning systems consists of 
importing patient images from imaging devices and contouring of the tumor volume 
and organs at risk [27]. In radiation therapy, CT imaging is the primary method of 
showing patient’s anatomical information because it provides a good visualization of 
the high-density organ structures and high accuracy of organs’ geometric information 
[16]. Additionally, CT uses x-rays for constructing images. It reveals the electron 
density information of different tissues, which is the essential information for dose 
calculation. 
Another image modality that is used rather often in radiation therapy is magnetic 
resonance image (MRI). Due to its high soft tissue contrast and ability to present 
information about tumor physiology and location [17], MRI is enabled to provide a 
more optimal set of images for target delineation and diagnostic interpretation [16].  
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In order to take advantages of both, correlating the two image data sets together is 
often performed in modern treatment planning systems. This kind of imaging 
procedure is so called image registration. 
4.1.3 Input	  of	  Treatment	  Parameters	  
In treatment planning, treatment parameters are defined to describe the characteristics 
of the radiation beam. These parameters can be machine identification, 
source-to-surface distance value or source-to-axis distance value, field size, gantry 
rotation and etc. For a computerized treatment planning system, it is elementary to 
provide ways to enter and express these treatment parameters in certain manners. 
Furthermore, in order to utilize TPS to try more radiation beam combinations, it is 
important to consider the usability of handling the treatment parameters [27]. 
4.1.4 Treatment	  Plan	  Visualization	  and	  Output	  
This aspect describes the capability of a computerized treatment planning systems to 
display anatomical and dose distribution data in graphic form [27]. 
4.1.5 Optimization	  
Optimization is a procedure for selecting treatment plan according to a number of 
predefined criteria. However, the criteria are often difficult to establish because of its 
high dependency on human judgment. For optimization in computerized treatment 
planning systems, it expresses the predefined criteria into several constraints3 and 
then makes use of treatment parameters as variables to achieve the objective [27]. 
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4.2 Treatment	  Planning	  Process	  Based	  on	  TPS	  
In this section, the most common case will be demonstrated to illustrate the general 
process of treatment planning in TPS. 
4.2.1 Patient	  Identification	  and	  Image	  Preparation	  
In the first step, patient identification information and images will be created or 
imported into the treatment planning system. The patient identification information 
usually contains patient’s name, gender, age, nationality and etc. Image preparation 
usually consists of importing images, connecting images to current patient, creating 
3D image4, and image registration [24,28]. 
It is worth to mention that in order to achieve the common usability and accessibility 
of patient data and images between different hospitals, DICOM (Digital Imaging and 
Communication in Medicine) file standard is implemented. Nowadays, DICOM is 
accepted extensively in clinics to handle patients’ radiology information. The 
elementary DICOM file contains patient’s images, name, age, gender and etc.; 
additionally the DICOM RT (DICOM in radiation therapy) contains RT Image, RT 
Doses, RT Structure Sets, RT Plans and RT Treatment Records [28]. 
4.2.2 Image	  Segmentation	  
Originally, image segmentation, which is also known as contouring, refers to 
delineation of anatomic region of interest on patient image, slice by slice. The 
interesting structures can be, for example, external treatment couch outlines, tumor 
target, critical tissues, anatomic landmarks and etc. Usually, by using computerized 
treatment planning system, it is now possible to segment the respect structures 
automatically in three dimensions based on image contrast and so on. Concerning the 
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accuracy of contouring the tumor, fully automated image segmentation is not accepted 
without clinician’s review. Additionally, for certain kinds of cancers, some areas of 
clinical target volume are not visible on the diagnostic images. It very much lies on 
the clinician’s experiences to determine the actual volume. 
4.2.3 Plan	  Setup	  
After image segmentation has been completed, radiation physicist or dosimetrist will 
start creating treatment plans using computerized treatment planning system, based on 
the dose prescriptions given by radiation oncologist. Creation of these plans consists 
of defining the beam number, beam geometry, beam modifiers and so on. 
Additionally, defining radiation constraints for target volume and normal tissues are 
also included in plan setup for certain treatment technologies (e.g. inverse treatment 
planning, in which optimization is applied) [16]. 
4.2.4 Dose	  Calculation	  and	  Plan	  Evaluation	  
By using corresponding dose calculation algorithm, dose distribution can be 
determined and viewed in 3D display. Afterwards, radiation oncologist will compare 
and evaluate the doses that have been calculated from different treatment plans. At the 
final step, treatment plan that best fulfills the overall treatment objectives will be 
selected or combined from multiple plans [7]. 
4.2.5 Treatment	  Plan	  Approval	  
At this stage, treatment plan shall be reviewed and approved by prescribing radiation 
oncologist, to indicate that the treatment plan has been evaluated and completed. Only 
the plan with approved state can be used to treat the patient later. It is also important 
for a TPS to provide a data locking after plan has reached “approved” stage. This 
prevents unauthorized or unintentional modifications to a completed plan in TPS.
   
5 Risk Management for Medical Devices 
Risk management is a crucial activity for radiation device manufacturers to eliminate 
or reduce the risk that may cause harms to the health people. The checking functions 
for which the automated tests are created in the TPS are related to the risk 
management. Therefore the principle of the risk management will be presented in 
following section. 
5.1 Risk	  Management	   	  
According to standard ISO 14971:20075, risk management is referred as “systematic 
application of management policies, procedures and practices to the tasks of analyzing, 
evaluating, controlling and monitoring risk” [29]. As one kind of medical devices, 
treatment planning system is required to comply with this standard and to implement 
risk management framework to ensure that it is safe to use for all its customers, and to 
ensure all residual risks are clearly identified and communicated with its all customers 
[30]. For the purposes of this section, the following terms and definitions will be 
explained with associations of radiation therapy: 
• Harm: Physical injury or damage to the health of people, or damage to 
property or the environment [29]. In terms of radiation therapy, harms can be: 
damage to healthy tissue due to radiation, tumor control is not effective 
enough, physical contact injury, cardiac arrest and etc. 
• Hazard: Potential source of harm [29]. This term describes the origin or the 
nature of the expected harm [30]. For instance, overexposing to the radiation 
can be a potential source of harm, which could impair patient healthy tissues; 
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or encountering a treatment machine collision can be a potential source of 
harm, which could physically injure patient healthy body. 
• Hazardous situation: Circumstance in which people, property, or the 
environment are exposed to one or more hazard(s) [29]. 
• Hazard cause: Event or a sequence of events that could initiate hazardous 
situation [29]. 
5.1.1 Risk	  Management	  Process	  
In standard ISO 14971-2007, risk is interpreted as “combination of probability of 
harm and severity of that harm” [29]. With the purpose of reducing the probability 
and the severity of the harm, specific requirements are defined in this standard for 
establishing a systematic risk management framework for medical device 
manufacturers. This includes following aspects: risk management process, risk 
management responsibilities, qualification of personnel, risk management plan and 
risk management file [29]. Concerning the main subject of this chapter, only risk 
management process will be discussed in detail. 
For a manufacture of a medical device, defining a risk management process is strictly 
required for the reason of ensuring all risk management activities are in process[29]. 
The following elements are essential for this process: 
• Risk analysis 
• Risk evaluation 
• Risk control 
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• Evaluation of overall residual risk acceptability 
• Risk management report 
• Production and post-production information 
5.1.2 Risk	  Analysis	  
Risk management process shall begin with risk analysis when new characteristics of 
the medical device that could affect safety are identified [29]. 
Firstly, product’s intended uses and reasonably foreseeable misuses shall be evaluated 
and documented [29]. Based on these information possible hazards associated with 
the product will be identified. 
At next stage, hazardous situations and hazard causes shall be estimated and well 
documented based on the identified hazards. It is worth to notice that hazardous 
situations may not only arise from faults, normal uses may also lead to a hazardous 
situation. Finally, by estimating both severity and probability of occurrence of 
associated harm, risk can be assessed. 
5.1.3 Risk	  Evaluation	  
Risk evaluation is the phase where manufacturer will decide the acceptability of 
identified risks [29]. Normally manufacturer will define a set of criteria for deciding 
which hazardous situation requires risk controls [29]. This set of criteria is made 
based on the severity and probability of occurrence of the harm. For example, if an 
identified hazard cause has a high probability to arouse a serious harm to the patient, 
then a risk control is firmly needed for the risk associated to this hazard cause. In 
contrary, if the hazard cause only seldom causes a very limited harm to the patient, 
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then it is within acceptable level and implementing risk control is optional. 
5.1.4 Risk	  Control	  
Risk control is the phase where all the measures for reducing the identified risks to 
acceptable level are implemented. Manufacturer is required to use one or more of the 
following risk control options in the priority order listed [29]: 
• Inherent safety by design 
• Protective measures in the medical device itself or in the manufacturing 
process 
• Information for safety 
The priority order listed here is important. If practicable, manufacturer should first 
consider design the product to be inherently safe. This can be conducted by defining 
safety requirements in product design, and having them verified and validated when 
product is finalized. If this is not practicable, then protective measures such as barriers 
and alarms should be taken to reduce the risk to ALARP (as low as reasonably 
practicable) level [29]. The least preferred protective measure is a written warning 
[29]. 
After the risk control measures have been implemented, it is important for 
manufacturer to perform a verification and validation actions. Verification action is to 
ensure risk control measure is correctly implemented into the product according to the 
design. Validation action is to measure the effectiveness of the risk control measure 
[29]. If there are still residual risks remain in the product, manufacturer should 
perform further evaluations on them to determine their accept abilities using the same 
criteria mentioned in section 5.1.3. If the residual risk is not within acceptable level, 
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then additional risk control measures shall be applied. This iterative procedure will be 
continued until residual risk is reduced to acceptable level [29]. 
However, there are some occasions where the residual risk is still greater than 
manufacturer’s criteria for acceptable risk. In order to provide such high-risk medical 
device to customers, manufacturer is required to make a careful evaluation on the risk 
and to show that the benefit of the medical device is over the risk [29]. 
5.1.5 Evaluation	  of	  Overall	  Residual	  Risk	  Acceptability	  
At this point, manufacture is required to evaluate on the combined impact of the 
individual residual risks. For a complex medical device with a large number of risks, 
it is possible that the overall residual risk can exceed the criteria for acceptable risk, 
even though individual risks do not [29]. 
5.1.6 Risk	  Management	  Report	  
Risk management report shall be completed as a summary of the result for the entire 
risk management process. It shall include the traceability for each identified hazard to 
the risk analysis, risk evaluation, risk control measure, and the final assessment [29]. 
5.1.7 Production	  and	  Post-­‐production	  information	  
It shall be emphasized that risk management does not end when medical device goes 
to production. The information of using the medical device from actual users can be 
useful to re-estimate the risks of the medical device and to refine the current risk 
management system. Therefore, it is extremely crucial and strictly required for 
manufacturer to implement a systematic mechanism for handling the user feedbacks 
or complaints [29]. 
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5.2 Risks	  Associated	  to	  Treatment	  Planning	  System	  
In radiation therapy, the most typical hazard that can ultimately result in harm to the 
patient is overexposure or underexposure of ionizing radiation [29]. With 
overexposure, patient’s healthy tissue may be damaged, whereas with underexposure, 
patient’s cancer cell may not be effectively controlled. Both cases can result in serious 
consequence, at worst death. This hazard can be initiated from different phases of 
radiation therapy, for instance, treatment planning phase. 
In treatment planning phase, in order to design and select a suitable treatment for the 
patient, the computerized treatment planning system is often used to simulate the 
patient setup, arrange the treatment beams, design the shielding, calculate the dose 
and etc. [31]. This means treatment planning system will provide adequate inputs for 
the real treatment delivery, and at mean time, some of the inputs may introduce risks 
into the radiation treatment.
   
6 Software Testing 
This chapter introduces the general concept and methods of software testing to help 
presenting the implementation work in following chapters. 
One of the most well known definitions of software testing is that: software testing is 
the process of executing a program or application with the intention of finding 
software errors, instead of demonstrating that the software performs its intended 
functions correctly [32]. This sounds more destructive than constructive while most of 
human beings hold the positive views in their life. Nevertheless the initial drive of 
performing test to a piece of software is to substantially add value to it, which can be 
further interpreted as raise the quality and reliability of the software [32]. Finally, to 
enhance the quality of the software, it simply means finding and removing errors. 
Therefore software testing should not be carried out with the intention to prove that 
software does what it is supposed to do; rather, it should be started with the 
psychology that the more errors are found the more successful the test is. 
6.1 Basics	  of	  Software	  Development	  Life	  Cycle	  Models	  
In order to understand software testing thoroughly, it is essential for one to get 
familiar with the basics of software development life cycle. It could help testers to 
form an awareness of what could go wrong in the process of software development 
and indicating the fragile areas.  
The life cycle of software development is a complicated study, which includes various 
procedures and many sophisticated methods. In this section, the most common models 




Figure 6.1: The waterfall model for software development 
6.1.1 Spiral	  Development	  Model	  
Spiral development model is a refinement of waterfall development model. It inherits 
the basic flows from waterfall development model whereas fractionizes the whole 
development cycle into several small cycles in order to address the problem 
mentioned in 0 [33]. This is illustrated in the Figure 6.2. 
• Analysis Phase: In this phase, the system requirements are defined in as much 
detail as possible. This may include collecting views from customers and 
arranging brainstorming sessions among related specialists. 
• Design Phase: At this phase, the preliminary design shall be created and it will 
get more and more perfection when the whole process goes on. It is worth to 
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mention that unlike the software design phase in waterfall model, this phase 
does not require any implementation work, and in contrary the main focus is 
on making up and refining the development strategy in order to resolve any 
possible risk in system requirements. 
• Implementation Phase: This is the real construction phase, in which all 
engineering work should strictly follow the design strategy proposed in design 
phase. 
• Testing Phase: This is the phase where the product is tested. It is quite similar 
to the one defined in waterfall model. 
• Deployment Phase: Real installation will occur in this phase, and product will 
be verified partially. After this phase, process shall be iterated into another 
identical development cycle and finally product will be finalized. 
 
Figure 6.2: The spiral model for software development 
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6.1.2 Test-­‐driven	  Development	  Model	  
Test-driven development requires developers to start to write test cases against 
existing requirements prior to the actual software developing. Initially, all the test 
cases should fail because no implementation has been done. If one passes, then most 
likely, there is a defect in the test case. In the next step, developers shall write the 
code with the only intention of passing the tests and no additional functionalities 
should be added. In the end of development process, all the implementation work 
should be done with passing all the test cases. This also means that software has fully 
fulfilled the requirements. Finally, developers can refine the code if needed, and by 
running the tests, it ensures that no functionality is broken [34]. 
6.2 Software	  Testing	  Terms	  and	  Definitions	  
From the previous section, it can be learned that software testing is essential for 
software development. Although the purpose of software testing is to discover as 
many bugs and defects as possible, it eventually raises the reliability of the final 
product [32]. This section will reveal the fundamental concepts of software testing by 
discussing its basic terms. 
6.2.1 Verification	  and	  Validation	  
Verification and validation are quite similar semantically. However, the differences 
between them are quite important in software testing [33]. As it is mentioned in 
section 6.1, software should always be deployed according to the approved software 
requirements, which are defined according to the customers’ need. Software 
verification is the phase to check that software complies with all the requirements, 
whereas software validation is the phase to ensure that the software meets the 
customers’ need. The reason for testing the software in two phases is that software 
requirements do not always correctly or fully interpret customers’ need. Therefore 
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verifying the specific requirements and validating the final product are very important 
practices in software testing. 
6.2.2 Quality	  and	  Reliability	  
Quality as it is defined in Merriam-Webster’s Collegiate Dictionary is a “degree of 
excellence”. To measure the quality in a piece of software, it very much relies on how 
extensive it meets customers’ need [33]. Reliability is the term to describe the stability 
of software. If the software has been tested to be stable, dependable and reliable, it 
does not assure the software of good quality unless it has been also validated to meet 
costumers’ need.  
Therefore, in order to achieve the high quality of the final product, software testers 
have to verify and validate the software throughout the development process to ensure 
that the final product meets the customers’ need while also being stable enough. [33]. 
6.2.3 Testing	  and	  Quality	  Assurance	  
Testing and quality assurance refer to processes or groups for verifying and validating 
the software product. It is easy to notice that there are some overlaps between these 
two terms. However, there are two key definitions to distinguish their responsibilities: 
• Testing is the process that focuses on finding software errors and bugs. 
• The goal of quality assurance is to create and enforce standards and methods 




6.3 Basic	  Taxonomy	  of	  Software	  Testing	  Techniques	  
6.3.1 White	  Box	  Testing	  and	  Black	  Box	  Testing	  
White box testing refers to a test approach by which tester can access to the program’s 
code and examine it. Based on what tester has seen in the code, fragile areas or critical 
functions may be revealed and testers can then tailor his or her testing based on such 
information [33]. White box testing can be seen as an effective method. However, it 
has a general risk that testers may fall into an objectively testing behavior in which 
test cases may be created to match the code’s operation. 
In black box testing, tester only knows the software functionalities that it suppose to 
have and without knowing anything about the software operational details. Based on 
this, tester types in a certain input and will check if the actual output is the same as 
expected [32]. 
6.3.2 Unit	  Testing	  and	  Integration	  Testing	  
Unit testing is a method to test small pieces of code, which usually can be single 
functions or methods. This approach can be considered as white box testing, which 
allows tester to examine the internal parts of software and it usually happens along 
with software development [35]. Therefore, the goal of unit testing is to ensure that 
individual parts of the software are correctly implemented and functioned. Later on 
when unit tested modules are combined together, integration testing will take place to 
ensure high-level functionalities operate as expected. 
6.3.3 Regression	  Testing	  
Regression testing is a test method to ensure that previous functionalities are still 
working after changes that have been made to the software or relevant code. The 
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triggering events can be discrepancy fixing, code refining, introducing new functions 
and so on. The most common and effective way to do regression testing is to build up 
a set of standard tests library that can be run every time when there is a new version of 
software build [36]. 
6.3.4 Automated	  Testing	  
Automated testing is a term opposite to manual testing. It uses a programmed 
application to execute a sequence of test cases without human interaction [37]. This 
approach helps eliminate human errors and provides faster results. As reported in 
section 6.3.3, software development may require running set of test cases multiple 
times. Thus, automated testing leads to significant labor cost savings over time.
   
7 Automated Testing Tool CppUnit 
This chapter will discuss an automated testing tool called CppUnit, which is the 
testing framework tool that has been used in this thesis work. 
7.1 Background	  of	  CppUnit	  
CppUnit is an open source unit testing framework, and it was originally ported from 
JUnit, by Michael Feathers and Jerome Lacoste. Its basic usage is based on C++ 
programming and it inherits many advanced features from C++ language, such as 
templates, abstract classes, nested classes, and the STL (Standard Template Library) 
[38]. Besides, its allowing testers to create test cases that can be run automatically at 
any software development phase has helped testers to keep confidence in quality of 
the code [34]. 
7.2 Architecture	  of	  CppUnit	  
CppUnit testing framework consists of 24 ordinary classes, 4 abstract classes, 7 
template classes, and several nested classes and help macros [34]. Most of the code is 
implemented under namespace “CppUnit”, as shown in Figure 7.1. “Asserter” 
namespace contains assertion functions used in test asserting. “TestAssert” 
namespace contains function templates used for comparison asserting. “Ui” namespace 
contains test user interfaces for text, MFC and QT6 versions [38]. 
 
                                                        
6 QT is a cross-platform application and UI framework, which contains an integrated development 
environment (IDE) 
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Figure 7.1: The CppUnit namespaces [34] 
Logically, the whole framework can be divided into following parts [38]: 
• Core: The core of CppUnit follows a design pattern called Composite Pattern, 
which can be described as composing several objects into tree structures that 
represent whole-part hierarchies [39]. The core of CppUnit defines basic 
elements for test case creation, test suite handling, test execution and 
termination, test result collection and test assertion. 
• Output: This part provides tool classes for outputting test results. CppUnit 
supports several output method such as by pure text, by XML markup 
language, or by different IDEs. 
• Helper: This part provides helper classes to assist the whole framework. In 
primary, most of the helper classes are related to test cases creation and 
arrangement. 
• Extension: Besides offering functions for performing unit testing, CppUnit has 
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also been extended to support other features, such as, repeated testing, which 
enables test cases to be executed for certain amount of times to test robustness 
of the test subject. 
• Listener: This part provides listener function in two different situations. Firstly, 
when a test run is finished, test listener will simply monitor whether the test is 
passed or failed and will forward test result to output section to handle. 
Secondly, test listener is used to monitor the test progress status during the 
execution. If any error occurs, it will forward the error message to standard 
error output device. 
• Portability: CppUnit has defined several configurable system variables or a 
series of macros in header file portability.h to make it become compatible with 
difference platforms. 
7.2.1 The	  Key	  Test	  Classes	  
 
Figure 7.2 Deriving structure for key test classes [34]. 
The most fundamental classes for CppUnit are shown in Figure 7.2 [34]. Test class is 
an abstract class for all test classes and describes their basic behaviors. TestFixture 
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class is also an abstract class. It is used to provide a common environment for a set of 
test cases [38]. TestFixture wraps a test case with setUp() and tearDown() method 
in order to create separate fixture for each test runs. As it shows in Figure 7.2, 
TestCase class is derived from Test and TestFixture classes to represent an actual 
test object, and TestSuite is a composite for other relevant test objects [34]. 
7.2.2 Test	  Results	  Collection	  Classes	  
 
Figure 7.3: Deriving structure for test result collection classes [34]. 
Figure 7.3 reveals the mutual dependencies between test result collection classes. 
TestListner is a basic class for observing test results. When error occurs, 
TestSucessListener will be informed and TestListner will interface TestResult 
class to retrieve the test result. SynchronizedObject class is used to manage objects 
that need to be synchronized. In this case, they are TestResult class and 
TestSucessListener class [34]. This allows test case to run separately with the test 
listener [34]. 
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7.2.3 Test	  Output	  Classes	  
 
Figure 7.4 Deriving structure for output classes [34]. 
Test output classes provide methods to print the test results to end users in 
human-readable text format [34]. As it shows in Figure 7.4, the structure of output 
classes is simple. As a base class, Outputter provides only a virtual class write(), 
which will be derived by TextOutputter, XmlOutputter and CompilerOutputter 
classes [38]. Those three classes will overload write() method to adapt it to different 
output format. 
   
8 Implementations 
This chapter reveals the goals and design of the actual implementation of this thesis. It 
focuses on presenting the designed test procedure and some important functions. 
8.1 Goals	  
This thesis is conducted to implement automated tests for a set of checking functions 
that are used for detecting cases that violate specific rules in the TPS. There are 
several essential points in implementing these tests. Firstly, the requirements of these 
checking functions need to be analyzed elaborately, so that created test cases can be 
properly conformed to the associated requirements. Secondly, tests shall be designed 
to have as short execution time as possible so that the cost arises from the time that 
tester consumes at running the tests can be limited. Thirdly, test cases shall be 
reusable so that they can be utmost utilized in the future, e.g. in regression testing. 
In this chapter, the actual implementation work will be presented in limited scope for 
the reason of protecting company’s confidentiality. 
8.2 Design	  
The requirements of the checking functions specify the rules that shall be fulfilled. If 
there is a violation, error or warning message shall be shown to the users and certain 
further actions shall be prevented in TPS. This thesis uses the principle of black box 
testing. Rather than exploring defects in identified fragile areas of the source code, 
test examines the actual functions that are implemented according to the requirements. 
To be more specific, test will try to generate each negative case which violates the 
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rule, by modifying the related attributes and then to verify whether the given warning 
or error is correct or not.  
8.2.1 Test	  Procedure	  
Figure 2.2 shows the test procedure in general. It also reveals basic design concept of 
this thesis work. 
 
Figure 8.1 Flowchart of the Test Procedure 
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Firstly, before running the tests, some prerequisite data has to be prepared and 
imported into a database beforehand. In addition, valid cases7 are created and stored 
in a network-shared repository. 
In the next step, test will be executed. To begin with, the prerequisite data and the 
valid case will be imported respectively from database and testing repository. Then 
the checking functions will be called to verify the original case in order to test the 
correctness and the integrity of the testing data. This pre-checking mechanism ensures 
that all the testing data are suitable to continue to run the test and there will be no 
confusion in the final test results. Without any exception, verifying at this stage 
should always pass; otherwise, any warning or error will be considered as a failure, as 
shown in the Figure 8.1. 
In the following step, test run will modify certain attributes with the intention to 
violate the specific requirement. It is important that the modification of the attributes 
is made only according to the relevant requirement that is being tested. This is due to 
the fact that some of the attributes are associated to several requirements and 
modifying one will cause violations of multiple requirements, which will cause some 
confusion in the testing result later on. After then, calling the checking functions 
should give expected warning or error per the requirement. In such way, the tested 
functional unit and its requirement shall be identically associated. If the expected 
error or warning is not properly thrown, it then indicates the implementation failed to 
comply with the requirement and test case should also be failed. 
Last stage is the result collection and test termination. The test result will be logged 
into a log file, after then the test run will be terminated. It is noteworthy that before 
the test termination, test run will revert all the modifications that have been made to 
the system. This avoids saving any changes to the database to ensure the consistency 
                                                        
7 Valid cases refer to the cases that are already verified by checking functions. 
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of the test environment, so that following test cases can be executed under the same 
conditions. 
8.2.2 Other	  Features	  of	  the	  Test	  
In this thesis, CppUnit testing framework is used to achieve the test automation. It 
composes all the test cases into one test suite and allows them to be executed 
repeatedly in any software build. This process has very few human interactions. 
Therefore it is also timely efficient. 
Additionally, the assertion mechanism in this thesis is meticulously designed. As it is 
stated before, the primary goal of this thesis is to test the detectability of the checking 
functions for rule violations. One method to check this is by comparing the actual 
thrown messages with the expected ones. This method will only work if the messages 
that are shown to the users are relatively stable, meaning that they rarely need to be 
changed in the later releases. However, this can be hardly guaranteed, as there is 
always need to make the error or warning messages more descriptive to the users in 
the future. Also, localizing the messages to different languages will also break this 
method. Due to these concerns, this test includes the requirement unique IDs8 and 
message types (error or warning) for verifying the correct error or warning messages, 
as modifying the requirement unique IDs and message types are remotely needed in 
the checking functions. It is also noticeable that applying this method needs additional 
effort in refining the software source code to associate each message with its unique 
ID and message type. 
Furthermore, logging mechanism in this thesis is well designed in order to make the 
trouble-shooting easier for the testing engineer. First of all, all actual thrown messages 
are printed in the test log, as well as the expected messages. Apart from this, there are 
three firm statements used for stating the different types of the failures in the test case: 
                                                        
8 The unique ID is defined for each message associated with the warning or error in the requirement. 
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• Message mismatching: When unique IDs are mismatched. 
• Message type mismatching: When unique IDs are the same but message type 
are mismatched 
• Message number mismatching: When there are more than or less than 
expected messages are thrown. 
Lastly, because of the high dependencies between different attributes, it is inevitable 
for some test cases that modifying one attribute may affect the others. Therefore, in 
these test cases, invalidating one specific case could trigger multiple warnings or 
errors and tests are designed to accept those additional warnings or errors.
   
9 Evaluation 
This chapter presents the scope of the test implementation and the evaluation of the 
final results. 
9.1 Test	  Acceptance	  Criteria	  
In this work, test is considered as passed only when the same number of correct 
warnings or errors is thrown after test run has broken the specific rule. The 
determination of the correct warning or error is by comparing its unique ID with the 
expected one. 
9.2 Test	  Result	  Summary	  
In this work, automated tests were created for 93 specific rules. All the tests are run 
for each nightly build at the target company. The results are generated from each 
nightly build. Figure 9.1 reveals the results that were captured at different points of 
test development phase. At the beginning of the test development, the failure rate was 
relatively high. This is due to the implementations of the new features and 
modifications of the existing code and requirements at the early phase of the software 
development. Besides, some of the test cases were not well implemented yet at this 
phase, which had also caused several failures. After February 2011, as the total 
number of the test cases increased, the failure rate declined gradually. This implies 




Figure 9.1 Captured test results at different point. Horizontal axis presents the dates when test results were 
captured. Vertical axis presents the percentages of the passed and failed test cases. 
The most typical software defects that have been detected by running these tests are 
summarized as following: 
• Specific rule of the checking functions has been broken on purpose, yet the 
associated warning or error is not shown. 
• Specific rule of the checking functions has been broken on purpose, yet 
non-related warning or error is shown in addition to the correct warning or 
error message. 
• A precondition has been invalidated on purpose, yet the dependent object is 
still valid. This reveals a corruption in data model dependency rule. 
• Some of the mandatory attributes are not correctly configured in the system. 
When the software source code is modified and refined in later releases, it is possible 























Therefore, these tests should be constantly maintained and updated. Furthermore, 
keeping the test running for each nightly build is a good mean to monitor the 
functional status of the checking functions.
   
10 Conclusions 
The goal of this thesis was to develop a set of comprehensive automated tests for a 
large set of checking functions in a radiation therapy treatment planning system in 
order to verify that correct error or warning message is shown. This thesis developed 
a set of automated tests for each specific rule of the checking functions. These tests 
verify that the implementations of the checking functions comply with pre-defined 
requirements. In order to demonstrate the work, this thesis started first by introducing 
the general knowledge of radiation therapy. The discussion focused on the external 
beam radiation therapy, especially on the linear accelerator machine. Later on, 
radiation therapy clinical stuffing and workflow were presented. This offered an 
overview on how treatment planning is carried out in clinics. In treatment planning 
phase, the treatment planning system is used to simulate the application of radiation to 
cancer patients. . It determines a lot of treatment parameters that are used for defining 
the beam shape and calculating the dose. In the following chapter, risk management 
was brought up with the intention of explaining the importance of risk control in 
radiation therapy and in treatment planning system. Finally, after introducing the 
software testing and the CppUnit testing framework, the actual implementation was 
done with the purpose of verifying the checking functions. After the implementation 
work was done, tests had exposed several defects in the checking functions, which 
have already been corrected by the time the thesis was published. Thus, it can be seen 
that this work has enhanced the reliability and the safety of the treatment planning 
system.  
In the future, these tests can be extended further to cover more recently defined rules. 
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